Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The clinical-trial page now presents the study record for Y90 radioembolization combined with nivolumab, including its status, eligibility criteria, treatment plan, and outcome measures, instead of an error page.
    Difference
    48%
    Check dated 2026-11-07T16:59:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T17:05:43.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T20:39:30.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:25:04.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:16:34.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study record URL now displays a 403 Forbidden error page, replacing the usual study details content. This indicates restricted access to the record rather than changes to the study data.
    Difference
    18%
    Check dated 2026-09-19T22:27:17.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.